AI4HOPE Dementia Pain Assessment Pilot Study 1
Launched by UNIVERSITY OF BONN · Feb 25, 2024
Trial Information
Current as of October 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The AI4HOPE Dementia Pain Assessment Pilot Study 1 is a research project aimed at creating and testing a new tool to help assess pain in patients with dementia. This study focuses on finding a reliable way to understand how patients with mild to moderate dementia experience pain, ensuring that the process is not too overwhelming for them.
To participate in this trial, individuals must have mild or moderate dementia and be able to give their consent or have someone else provide consent on their behalf. Participants should also be able to share their own experiences regarding their pain. It's important to note that people with severe cognitive impairment or other serious health issues may not be eligible for this study. While this trial is not yet recruiting participants, it will provide valuable insights that could help improve pain management for those living with dementia in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mild or moderate dementia of any type
- • Able to provide informed consent, or consent from surrogate decision maker
- • Able to self-assess patient-related outcome (PROM) or experience (PREM) measures
- Exclusion Criteria:
- • Ongoing delir
- • Severe cognitive impairment (MMSE \< 10 \[22\])
- • Unable to provide informed consent
- • Life expectancy estimated less than 3 months
About University Of Bonn
The University of Bonn is a renowned academic institution dedicated to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge clinical trials aimed at improving patient outcomes and advancing healthcare knowledge. Its comprehensive research programs are supported by state-of-the-art facilities and a commitment to ethical standards in clinical practice. By fostering partnerships with healthcare professionals and industry leaders, the University of Bonn plays a pivotal role in translating scientific discoveries into innovative therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lukas Radbruch, MD
Principal Investigator
Department of Palliative Medicine, University Hospital Bonn
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported